New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 7, 2014
16:20 EDTSUPNOrchard Hill Capital reports 7.5% stake in Supernus, will continue talks
Orchard Hill has had, and expects to continue to have, discussions with the company’s management and other shareholders regarding ways to maximize shareholder value, including the business, operations, governance, management, strategy, and future plans of the company. However, Orchard Hill now believes it would be beneficial to engage more substantively with the company's management. Orchard Hill may also take further steps including engaging in discussions with shareholders, management, the board and other interested parties regarding such matters as strategic alternatives including exploring a sale of the company.
News For SUPN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 5, 2016
16:05 EDTSUPNSupernus court win removes an overhang, says Northland
Subscribe for More Information
15:03 EDTSUPNCourt rules in favor of Supernus on two patents in suit with Actavis
The U.S. District Court for the District of New Jersey entered judgment against Actavis, now known as Allergan (AGN), and in favor of Supernus (SUPN) as to the '898 and '131 patents disputed in a lawsuit between the two companies. The court found against Supernus and in favor of Actavis as to the '600 patent, according to a court filing. The Patents-in-Suit relate to Supernus' Oxtellar XR drug indicated for the treatment of seizures. Shares of Supernus are up 29% in afternoon trading following the court ruling.
14:53 EDTSUPNSupernus jumps 21%, halted for circuit-breaker

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use